EuroPCR 2022 | The MITRA TUNE Registry

Left atrial enlargement with or without atrial fibrillation (AF), absence of valvular degeneration, and heart failure with preserved function have recently been identified as functional atrial mitral regurgitation (MR). This subtype of secondary MR currently appears to be underdiagnosed, and the need for treatment in the general population might be greater than predicted.

The MITRA TUNE Registry

The aim of this multicenter study was to analyze the 30-day and 2-year clinical and echocardiographic outcomes of patients who underwent transcatheter mitral valve repair.

Inclusion criteria were functional mitral insufficiency 3+/4+, LV diastolic diameter <55 without motility disorders; persistent, permanent, or paroxysmal AF, and normal valvular structure. 

Of the 1135 patients, 87 met the inclusion criteria. Mean patient age was 81 years old, and most subjects were female (61%). The Society of Thoracic Surgeons (STS) score was 4%. Technical success was 97%. The in-hospital death rate was 2%, the acute renal failure rate was 8%, and the major bleeding rate was 4.5%. At 30 days, the total mortality rate was 5% and the rate for cardiovascular death was 4%.

Mild or moderate MR was present in 98% of patients, and symptomatic improvement was observed in 79% of patients with functional class I/II within the first year of follow-up.

Echocardiographic analysis of the left atrium showed significant positive remodeling compared with baseline values and control outcomes within the first year. 

Read also: DISCO RADIAL: Conventional or Distal Transradial Access?

The rate for cardiovascular survival and hospitalization for heart failure in these patients was 55% at 2 years. A multivariate analysis showed that postprocedural MI ≥2+ and intercommissural annular diameter ≥35 mm were independent negative predictors.

Conclusion

In patients with functional atrial MR, transcatheter edge-to-edge repair of the mitral valve was shown to be safe and effective, inducing positive reverse remodeling of the left atrium and mitral annulus, improving symptoms.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez
Member of the Editorial Board of SOLACI.org.

Original Title: MItraClip in Atrial Functional mitral regurgitation: a multi-center experience. The MITRA TUNE Registry. 

Reference: Antonio Popolo Rubbio, et al. EUROPCR.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...

Is Angioplasty Always Necessary after TAVR?

Courtesy of: Silvina E. Gomez, MD The prevalence of coronary artery disease (CAD) in patients undergoing TAVR is high, ranging from 40 to 70%, according...

TAVR and Anticoagulation: What Should We Do?

Transcatheter aortic valve replacement (TAVR) has consolidated as a valid strategy for certain groups of patients. However, approximately one third of those who require...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions

The presence of coronary calcium significantly limits the success of percutaneous coronary interventions (PCI), primarily due to suboptimal stent expansion. This can lead to...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...